VIR BIOTECHNOLOGY INC's ticker is and the CUSIP is 92764N952. A total of 4 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41 | -98.3% | 4,400 | -95.4% | 0.00% | -100.0% |
| Q2 2023 | $2,362 | +2171.2% | 96,300 | +2040.0% | 0.00% | – |
| Q1 2023 | $104 | -3.7% | 4,500 | +4.7% | 0.00% | – |
| Q4 2022 | $108 | -100.0% | 4,300 | -84.8% | 0.00% | -100.0% |
| Q3 2022 | $543,000 | -35.6% | 28,200 | -14.8% | 0.00% | 0.0% |
| Q2 2022 | $843,000 | -18.9% | 33,100 | -18.1% | 0.00% | 0.0% |
| Q1 2022 | $1,039,000 | +100.2% | 40,400 | +225.8% | 0.00% | 0.0% |
| Q4 2021 | $519,000 | +399.0% | 12,400 | +415.0% | 0.00% | – |
| Q3 2021 | $104,000 | -3.7% | 2,408 | +4.9% | 0.00% | – |
| Q2 2021 | $108,000 | -57.1% | 2,296 | +1227.2% | 0.00% | – |
| Q1 2021 | $252,000 | – | 173 | +13.1% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 153 | +19.5% | 0.00% | -100.0% |
| Q3 2020 | $439,000 | +176.1% | 128 | +228.2% | 0.00% | – |
| Q2 2020 | $159,000 | +1123.1% | 39 | +875.0% | 0.00% | – |
| Q1 2020 | $13,000 | – | 4 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 91,400 | $856,418 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 4,400 | $41 | 0.00% |
| JPMORGAN CHASE & CO | 30,000 | $281,100 | 0.00% |